MAPKAPK2 and neoplasm: Lewandowska et al. showed tissue-level CCL3 expression rises with lymph node involvement, underscoring its link to metastatic potential [27], while Phinney et al. revealed an MK2-dependent feedback loop in which CCL3 not only fuels tumor growth but also amplifies inflammatory cytokine release [28].